A

Apellis Pharma (APLS)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Apellis Pharma (APLS)

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit ... Read more

Open
USD19.28
High
USD19.47
Low
USD19.07
52 Week High
USD41.94
Monthly Return
8.70%
Revenue
776M

Daily Vol.
241.40k
Avg. Daily Vol.
2.01M
Market Cap.
2.5B
52 Week Low
16.10
Annual Return
-51.80%

Stock News

You’d better know what kind of investor you are — because ‘risk happens fast’

You’d better know what kind of investor you are — because ‘risk happens fast’

MarketWatch

Trump says Friday tariff deadline 'will not be extended'

Trump says Friday tariff deadline 'will not be extended'

CNBC

DOJ urges release of Jeffrey Epstein and Ghislaine Maxwell grand jury info in new filings

DOJ urges release of Jeffrey Epstein and Ghislaine Maxwell grand jury info in new filings

CNBC

Companies from Stanley Black & Decker to Conagra are saying tariffs will cost them hundreds of millions

Companies from Stanley Black & Decker to Conagra are saying tariffs will cost them hundreds of millions

CNBC

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.